Business Description
Jianzhijia Pharmaceutical Chain Group Co Ltd
ISIN : CNE100004JG5
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.21 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 1.29 | |||||
Debt-to-EBITDA | 6.15 | |||||
Interest Coverage | 5.12 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.72 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.8 | |||||
3-Year EBITDA Growth Rate | 46.4 | |||||
3-Year EPS without NRI Growth Rate | 5.6 | |||||
3-Year FCF Growth Rate | 43.2 | |||||
3-Year Book Growth Rate | 14.6 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 67.6 | |||||
9-Day RSI | 61.28 | |||||
14-Day RSI | 55.93 | |||||
6-1 Month Momentum % | -12.82 | |||||
12-1 Month Momentum % | -28.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.83 | |||||
Quick Ratio | 0.31 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 142.1 | |||||
Days Sales Outstanding | 19.09 | |||||
Days Payable | 168.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.06 | |||||
Dividend Payout Ratio | 0.5 | |||||
Forward Dividend Yield % | 3.06 | |||||
5-Year Yield-on-Cost % | 3.06 | |||||
3-Year Average Share Buyback Ratio | -3.4 | |||||
Shareholder Yield % | -7.61 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 36.27 | |||||
Operating Margin % | 6.9 | |||||
Net Margin % | 4.23 | |||||
FCF Margin % | 5.07 | |||||
ROE % | 14.18 | |||||
ROA % | 4.06 | |||||
ROIC % | 7.19 | |||||
ROC (Joel Greenblatt) % | 23.01 | |||||
ROCE % | 11.64 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.71 | |||||
PE Ratio without NRI | 16.29 | |||||
Shiller PE Ratio | 26.8 | |||||
Price-to-Owner-Earnings | 142.93 | |||||
PEG Ratio | 0.39 | |||||
PS Ratio | 0.67 | |||||
PB Ratio | 2.11 | |||||
Price-to-Tangible-Book | 14.6 | |||||
Price-to-Free-Cash-Flow | 12.56 | |||||
Price-to-Operating-Cash-Flow | 7.58 | |||||
EV-to-EBIT | 13.62 | |||||
EV-to-EBITDA | 13.62 | |||||
EV-to-Revenue | 0.9 | |||||
EV-to-FCF | 17.74 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.62 | |||||
Price-to-Graham-Number | 3.25 | |||||
Earnings Yield (Greenblatt) % | 7.34 | |||||
FCF Yield % | 7.61 |